Gilead Sciences (GILD) returns

Biotechnology · NASDAQ · Health Care

$170.68 +3.06% Close Oct 30, 2026 Live

Gilead Sciences returns over 10 years

$1,000 invested in Gilead Sciences ten years ago was worth $3,292 at the close on October 30, 2026, with dividends reinvested: an average return of 12.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.

GILD, $10,000 investedS&P 500 (SPY)
$10,000$20,000$30,000$40,000
20172019202120232025

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month +14.5% — $1,145 -0.9%
3 months +30.7% — $1,307 +2.1%
Year to date +41.6% — $1,416 +11.7%
1 year +47.7% — $1,477 +12.4%
3 years +141.2% +34.1% $2,412 +88.5%
5 years +214.1% +25.7% $3,141 +76.0%
10 years +229.2% +12.7% $3,292 +316.6%

Gilead Sciences return by calendar year

YearGILDS&P 500 (SPY)Difference
2026 to date +41.6% +11.7% +29.9%
2025 +36.6% +17.7% +18.9%
2024 +18.6% +24.9% -6.2%
2023 -2.0% +26.2% -28.2%
2022 +23.6% -18.2% +41.8%
2021 +30.0% +28.7% +1.2%
2020 -6.6% +18.4% -25.0%
2019 +7.9% +31.2% -23.3%
2018 -9.9% -4.6% -5.4%
2017 +3.0% +21.7% -18.7%
2016 -27.6% +12.0% -39.6%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also: GILD financials · GILD valuation

No forecast, no recommendation. This page describes Gilead Sciences from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.